Subcategory Detail
Interagency Autism Coordinating Committee (IACC) logo
Office of Autism Research Coordination (OARC) logo

Medical/Pharmacologic$10,960,296.00
Fiscal Year: 2010
  

Download 2010 Medical/Pharmacologic projects (EXCEL)
This subcategory includes research on drugs (e.g., antidepressants, anticonvulsants, antipsychotics, anxiolytics, melatonin, and stimulants) to treat autism and its co-occurring conditions, as well as medical therapies such as transcranial magnetic stimulation (TMS).
Graph: The subcategories for Question 4 illustrate the many approaches to treatments and interventions supported by autism research funders. The largest amount of funding supported projects to develop Model systems and therapeutic targets (35%), followed by research on Behavioral interventions (29%). Medical/Pharmacologic interventions received 16% of funding, classroom-based interventions (Educational) received 10% of funding, and Technology-based interventions and supports received 7% of funding. The subcategories with the smallest amounts of funding included Occupational, physical, and sensory-based (2%) and Complementary, dietary, and alternative (1%).
Note: Initial Sort is by Principal Investigator. Sorting by other columns is available by clicking on the desired column header.
Project Title Principal Investigator Strategic Plan Objective Institution
Predictors of effects of propranolol on language & connectivity in autism Beversdorf, David Q4.S.F University of Missouri
The effects of oxytocin on complex social cognition in autism spectrum disorders Bartz, Jennifer Q4.L.A Mount Sinai School of Medicine
Neuronal nicotinic receptor modulation in the treatment of autism: A pilot trial of mecamylamine Arnold, L. Eugene Q4.L.A The Ohio State University
Intranasal oxytocin for the treatment of children and adolescents with autism spectrum disorders (ASD) Anagnostou, Evdokia Q4.S.C Holland Bloorview Kids Rehabilitation Hospital
2/3-Atomoxetine placebo and parent training in autism Aman, Michael Q4.S.F Ohio State University